[通过穿皮冠状动脉血管造形术进行心肌再血管化的ST段升高和不升高心肌梗塞之间的短期和长期死亡率比较]
Luis Gajardo N1, Juan Barramuño D1, Alicex González M2
1Departamento de Medicina Interna, Facultad de Medicina, Universidad de Concepción, Concepción, Chile.
Revista medica de Chile
|September 13, 2024
概括
患有ST升高心肌梗塞 (STEMI) 的患者面临更高的早期死亡率,而非ST升高心肌梗塞 (NSTEMI) 患者的长期死亡率更高. 在四年后,STEMI和NSTEMI组的整体存活率相似.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- ST升高心肌梗塞 (STEMI) 和非ST升高心肌梗塞 (NSTEMI) 是不同的急性冠状动脉综合征.
- 了解差异性死亡模式对于患者的管理和预后至关重要.
研究的目的:
- 在被诊断为STEMI的患者中比较早期和晚期死亡率与NSTEMI.
- 分析冠状动脉血管塑造术后这些患者群体的生存率.
主要方法:
- 在2013-2015年期间治疗的1838名患者的回顾性研究.
- 纳入标准:诊断为STEMI或NSTEMI,需要冠状动脉血管塑性术.
- 分析包括描述性统计,多变量分析和长达4年的生存分析.
主要成果:
- STEMI患者年轻,高血压和吸烟率较高.
- NSTEMI患者患有更多的糖尿病,较低的功能和复杂的冠状动脉疾病.
- 4年总生存率为76%,在各组之间没有显著差异.
- STEMI组在30天内死亡的风险更高 (p=0.012).
- 30天后,NSTEMI患者的死亡率更高 (80.8%vs75.6%的生存率).
结论:
- 在STEMI和NSTEMI患者之间,整体长期死亡率没有显著差异.
- STEMI与早期死亡风险的增加有关.
- NSTEMI与长期死亡风险的增加有关.
更多相关视频
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.3K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
相关概念视频
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...